{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:43:45Z","timestamp":1773287025594,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T00:00:00Z","timestamp":1416873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s11908-014-0445-6","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T14:31:30Z","timestamp":1417530690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Nervous System Lyme Disease"],"prefix":"10.1007","volume":"17","author":[{"given":"John J.","family":"Halperin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,25]]},"reference":[{"key":"445_CR1","unstructured":"Fenney DP. Living with Lyme disease, searching for answers. The Des Moines Register 2014 July 27, 2014."},{"key":"445_CR2","unstructured":"Centers for Disease CP. Reported cases of Lyme disease\u2014United States, 2012 [online]. Accessed July 30, 2014."},{"key":"445_CR3","doi-asserted-by":"crossref","unstructured":"Hinckley AF, Connally NP, Meek JI, et al. Lyme disease testing by large commercial laboratories in the United States. Clin Infect Dis. 2014;59(5):676\u201381.","DOI":"10.1093\/cid\/ciu397"},{"key":"445_CR4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-86-6-685","volume":"86","author":"AC Steere","year":"1977","unstructured":"Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med. 1977;86:685\u201398.","journal-title":"Ann Intern Med"},{"key":"445_CR5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJM198303313081302","volume":"308","author":"JL Benach","year":"1983","unstructured":"Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med. 1983;308:740\u20132.","journal-title":"N Engl J Med"},{"key":"445_CR6","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM198303313081301","volume":"308","author":"AC Steere","year":"1983","unstructured":"Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med. 1983;308:733\u201340.","journal-title":"N Engl J Med"},{"key":"445_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00005792-197907000-00001","volume":"58","author":"L Reik","year":"1979","unstructured":"Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE. Neurologic abnormalities of Lyme disease. Medicine. 1979;58:281\u201394.","journal-title":"Medicine"},{"key":"445_CR8","first-page":"404","volume":"101","author":"A Afzelius","year":"1910","unstructured":"Afzelius A. Verhandlugen der dermatorischen Gesellshaft zu Stockholm. Arch Dermatol Syphiligr. 1910;101:404.","journal-title":"Arch Dermatol Syphiligr"},{"key":"445_CR9","first-page":"765","volume":"71","author":"C Garin","year":"1922","unstructured":"Garin C, Bujadoux A. Paralysie par les tiques. J Med Lyon. 1922;71:765\u20137.","journal-title":"J Med Lyon"},{"key":"445_CR10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.7326\/0003-4819-99-1-22","volume":"99","author":"AC Steere","year":"1983","unstructured":"Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of the early manifestations of Lyme disease. Ann Intern Med. 1983;99:22\u20136.","journal-title":"Ann Intern Med"},{"key":"445_CR11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2340\/0001555564291295","volume":"64","author":"E Asbrink","year":"1984","unstructured":"Asbrink E, Hederstedt B, Hovmark A. The spirochetal etiology of erythema chronicum migrans Afzelius. Acta Derm Venereol. 1984;64:291\u20135.","journal-title":"Acta Derm Venereol"},{"key":"445_CR12","first-page":"235","volume":"31","author":"E Hollstrom","year":"1951","unstructured":"Hollstrom E. Successful treatment of erythema migrans Afzelius. Acta Derm Venereol. 1951;31:235\u201343.","journal-title":"Acta Derm Venereol"},{"key":"445_CR13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cid\/cit317","volume":"57","author":"K Ogrinc","year":"2013","unstructured":"Ogrinc K, Lotric-Furlan S, Maraspin V, et al. Suspected early Lyme neuroborreliosis in patients with erythema migrans. Clin Infect Dis. 2013;57:501\u20139.","journal-title":"Clin Infect Dis"},{"key":"445_CR14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijmm.2007.05.002","volume":"298","author":"V Fingerle","year":"2008","unstructured":"Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E, et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol. 2008;298:279\u201390.","journal-title":"Int J Med Microbiol"},{"key":"445_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.34.1.1-9.1996","volume":"34","author":"ME Aguero-Rosenfeld","year":"1996","unstructured":"Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34:1\u20139.","journal-title":"J Clin Microbiol"},{"key":"445_CR16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/mus.10451","volume":"28","author":"JJ Halperin","year":"2003","unstructured":"Halperin JJ. Facial nerve palsy associated with Lyme disease. Muscle Nerve. 2003;28:516\u20137.","journal-title":"Muscle Nerve"},{"key":"445_CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.43.1_Part_1.169","volume":"43","author":"S Hammers Berggren","year":"1993","unstructured":"Hammers Berggren S, Hansen K, Lebech AM, Karlsson M. Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology. 1993;43:169\u201375.","journal-title":"Neurology"},{"key":"445_CR18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/cit235","volume":"57","author":"JA Branda","year":"2013","unstructured":"Branda JA, Strle F, Strle K, Sikand N, Ferraro MJ, Steere AC. Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe. Clin Infect Dis. 2013;57:333\u201340.","journal-title":"Clin Infect Dis"},{"key":"445_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2012.09.003","volume":"75","author":"GP Wormser","year":"2013","unstructured":"Wormser GP, Schriefer M, Aguero-Rosenfeld ME, et al. Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn Microbiol Infect Dis. 2013;75:9\u201315. A good discussion of the issues regarding serologic testing and how to improve its sensitivity and specificity.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"445_CR20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/cit238","volume":"57","author":"RT Schoen","year":"2013","unstructured":"Schoen RT. Editorial commentary: better laboratory testing for Lyme disease: no more Western blot. Clin Infect Dis. 2013;57:341\u20133.","journal-title":"Clin Infect Dis"},{"key":"445_CR21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.21.5.819-825.1985","volume":"21","author":"GT Stiernstedt","year":"1985","unstructured":"Stiernstedt GT, Granstrom M, Hederstedt B, Skoldenberg B. Diagnosis of spirochetal meningitis by enzyme linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol. 1985;21:819\u201325.","journal-title":"J Clin Microbiol"},{"key":"445_CR22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.410300212","volume":"30","author":"K Hansen","year":"1991","unstructured":"Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi-specific immunoglobulin G, A, and M. Ann Neurol. 1991;30:197\u2013205.","journal-title":"Ann Neurol"},{"key":"445_CR23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1212\/WNL.39.6.753","volume":"39","author":"JJ Halperin","year":"1989","unstructured":"Halperin JJ, Luft BJ, Anand AK, et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology. 1989;39:753\u20139.","journal-title":"Neurology"},{"key":"445_CR24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10096-013-2014-6","volume":"33","author":"AJ Henningsson","year":"2014","unstructured":"Henningsson AJ, Christiansson M, Tjernberg I, Lofgren S, Matussek A. Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays. Eur J Clin Microbiol Infect Dis. 2014;33:797\u2013803.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"445_CR25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1742-2094-6-42","volume":"6","author":"TA Rupprecht","year":"2009","unstructured":"Rupprecht TA, Plate A, Adam M, et al. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation. 2009;6:42.","journal-title":"J Neuroinflammation"},{"key":"445_CR26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/00365548.2013.776700","volume":"45","author":"H Sillanpaa","year":"2013","unstructured":"Sillanpaa H, Skogman BH, Sarvas H, Seppala IJ, Lahdenne P. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children. Scand J Infect Dis. 2013;45:526\u201330.","journal-title":"Scand J Infect Dis"},{"key":"445_CR27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2377-13-2","volume":"13","author":"D Bremell","year":"2013","unstructured":"Bremell D, Mattsson N, Edsbagge M, et al. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol. 2013;13:2.","journal-title":"BMC Neurol"},{"key":"445_CR28","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM199610243351703","volume":"335","author":"MA Gerber","year":"1996","unstructured":"Pediatric Lyme Disease Study Group, Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL. Lyme disease in children in southeastern Connecticut. N Engl J Med. 1996;335:1270\u20134.","journal-title":"N Engl J Med"},{"key":"445_CR29","doi-asserted-by":"crossref","first-page":"725","DOI":"10.7326\/0003-4819-107-5-725","volume":"107","author":"AC Steere","year":"1987","unstructured":"Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med. 1987;107:725\u201331.","journal-title":"Ann Intern Med"},{"key":"445_CR30","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/cid\/ciu106","volume":"58","author":"JJ Halperin","year":"2014","unstructured":"Halperin JJ. Lyme disease\u2014neurology, neurobiology and behavior. Clin Infect Dis. 2014;58:1267\u201372. A review of many of the neurobehavioral issues that have confounded our understanding of Lyme disease and its nervous system manifestations.","journal-title":"Clin Infect Dis"},{"key":"445_CR31","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF02095652","volume":"113","author":"A Bannwarth","year":"1941","unstructured":"Bannwarth A. Chronische lymphocytare meningitis, entzundliche polyneuritis und \"rheumatismus\". Arch Psychiatr Nervenkr. 1941;113:284\u2013376.","journal-title":"Arch Psychiatr Nervenkr"},{"key":"445_CR32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.7326\/0003-4819-99-6-767","volume":"99","author":"AC Steere","year":"1983","unstructured":"Steere AC, Pachner AR, Malawista SE. Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. Ann Intern Med. 1983;99:767\u201372.","journal-title":"Ann Intern Med"},{"key":"445_CR33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0025-6196(11)65041-6","volume":"75","author":"L Zemel","year":"2000","unstructured":"Zemel L. Lyme disease and pseudotumor. Mayo Clin Proc. 2000;75:315.","journal-title":"Mayo Clin Proc"},{"key":"445_CR34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0887-8994(97)00215-4","volume":"18","author":"L Kan","year":"1998","unstructured":"Kan L, Sood SK, Maytal J. Pseudotumor cerebri in Lyme disease: a case report and literature review. Pediatr Neurol. 1998;18:439\u201341.","journal-title":"Pediatr Neurol"},{"key":"445_CR35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.1988.tb31834.x","volume":"539","author":"R Ackermann","year":"1988","unstructured":"Ackermann R, Rehse KB, Gollmer E, Schmidt R. Chronic neurologic manifestations of erythema migrans borreliosis. Ann N Y Acad Sci. 1988;539:16\u201323.","journal-title":"Ann N Y Acad Sci"},{"key":"445_CR36","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00234-005-1440-2","volume":"47","author":"P Kalina","year":"2005","unstructured":"Kalina P, Decker A, Kornel E, Halperin JJ. Lyme disease of the brainstem. Neuroradiology. 2005;47:903\u20137.","journal-title":"Neuroradiology"},{"key":"445_CR37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","volume":"17","author":"A Mygland","year":"2010","unstructured":"Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17:8\u201316. e11-14. An important overview of the diagnostic and therapeutic issues in European neuroborreliosis.","journal-title":"Eur J Neurol"},{"key":"445_CR38","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/brain\/113.4.1207","volume":"113","author":"JJ Halperin","year":"1990","unstructured":"Halperin JJ, Luft BJ, Volkman DJ, Dattwyler RJ. Lyme neuroborreliosis\u2014peripheral nervous system manifestations. Brain. 1990;113:1207\u201321.","journal-title":"Brain"},{"key":"445_CR39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01.WNO.0000166060.35366.70","volume":"25","author":"P Sibony","year":"2005","unstructured":"Sibony P, Halperin J, Coyle P, Patel K. Reactive Lyme serology in patients with optic neuritis and papilledema. J Neuro Ophthal. 2005;25:71\u201382.","journal-title":"J Neuro Ophthal"},{"key":"445_CR40","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archneur.1991.00530230033017","volume":"48","author":"LB Krupp","year":"1991","unstructured":"Krupp LB, Masur D, Schwartz J, et al. Cognitive functioning in late Lyme borreliosis. Arch Neurol. 1991;48:1125\u20139.","journal-title":"Arch Neurol"},{"key":"445_CR41","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1212\/WNL.41.10.1571","volume":"41","author":"JJ Halperin","year":"1991","unstructured":"Halperin JJ, Volkman DJ, Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology. 1991;41:1571\u201382.","journal-title":"Neurology"},{"key":"445_CR42","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.40.9.1340","volume":"40","author":"JJ Halperin","year":"1990","unstructured":"Halperin JJ, Krupp LB, Golightly MG, Volkman DJ. Lyme borreliosis-associated encephalopathy. Neurology. 1990;40:1340\u20133.","journal-title":"Neurology"},{"key":"445_CR43","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1097\/01.mlr.0000182493.57090.c1","volume":"43","author":"N Luo","year":"2005","unstructured":"Luo N, Johnson J, Shaw J, Feeny D, Coons S. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med Care. 2005;43:1078\u201386.","journal-title":"Med Care"},{"key":"445_CR44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.amjmed.2013.02.014","volume":"126","author":"MS Klempner","year":"2013","unstructured":"Klempner MS, Baker PJ, Shapiro ED, et al. Treatment trials for post-Lyme disease symptoms revisited. Am J Med. 2013;126:665\u20139. A summary of treatment trials in post treatment Lyme disease.","journal-title":"Am J Med"},{"key":"445_CR45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0404.2012.01690.x","volume":"127","author":"R Eikeland","year":"2013","unstructured":"Eikeland R, Mygland A, Herlofson K, Ljostad U. Risk factors for a non-favorable outcome after treated European neuroborreliosis. Acta Neurol Scand. 2013;127:154\u201360.","journal-title":"Acta Neurol Scand"},{"key":"445_CR46","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089\u2013134.","journal-title":"Clin Infect Dis"},{"key":"445_CR47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/01.wnl.0000265517.66976.28","volume":"69","author":"JJ Halperin","year":"2007","unstructured":"Halperin JJ, Shapiro ED, Logigian EL, et al. Practice parameter: treatment of nervous system Lyme disease. Neurology. 2007;69:91\u2013102.","journal-title":"Neurology"},{"key":"445_CR48","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ene.12420","volume":"21","author":"D Bremell","year":"2014","unstructured":"Bremell D, Dotevall L. Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension. Eur J Neurol. 2014;21:1162\u20137. Evidence that oral doxycycline may be effective in the most severe forms of nervous system Lyme disease.","journal-title":"Eur J Neurol"},{"key":"445_CR49","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/ene.12440","volume":"21","author":"JJ Halperin","year":"2014","unstructured":"Halperin JJ. Oral treatment of parenchymal central nervous system neuroborreliosis\u2014are we there yet? Eur J Neurol. 2014;21:1147\u20138.","journal-title":"Eur J Neurol"},{"key":"445_CR50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4997\/JRCPE.2010.314","volume":"40","author":"JJ Halperin","year":"2010","unstructured":"Halperin JJ. Nervous system Lyme disease. J R Coll Physicians Edinb. 2010;40:248\u201355.","journal-title":"J R Coll Physicians Edinb"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-014-0445-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-014-0445-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-014-0445-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:29:01Z","timestamp":1717597741000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-014-0445-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,25]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1007\/s11908-014-0445-6","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,25]]},"article-number":"445"}}